Ï㽶ÊÓƵ

Home

Jonathan Kimmelman

Academic title(s): 

James McGill Professor;
Associate Member of the Dept of Experimental Medicine

Jonathan Kimmelman
Contact Information
Email address: 
jonathan.kimmelman [at] mcgill.ca
Address: 

2001 McGill College Avenue,
11th floor, #1155

Phone: 
514-398-3306
Degree(s): 

PhD in Molecular Biophysics and Biochemistry from Yale University

Department: 
Equity, Ethics and Policy
Biography: 

Jonathan Kimmelman, PhD, is James McGill Professor of Biomedical Ethics at Ï㽶ÊÓƵ. His research group, STREAM (Studies in Translation, Ethics and Medicine) uses empirical and theoretical methods to understand the ethical, policy, and scientific dynamics of developing new drugs. Kimmelman received the Maud Menten New Investigator Prize (2006), a CIHR New Investigator Award (2008), a Humboldt Bessel Award (2014), and was elected a Hastings Center Fellow (2018). He has sat on various advisory bodies within the U.S. NHLBI and NIAID, served for four tours of duty on U.S. National Academies of Medicine committees, and chaired the International Society of Stem Cell Research Guidelines for Stem Cell Research and Clinical Translation revision task force 2015-16. His research has been covered in major media outlets, including NPR’s All Things Considered, STATNews, and Nature. Kimmelman is deputy editor at Clinical Trials, and associate editor at Med.

Courses: 

 PHIL 543B: Medical Ethics: The Ethics of Human Experimentation

Research areas: 
Biomedical Ethics
Research Ethics
Areas of interest: 

Jonathan Kimmelman's research centers on the ethical, social, and policy challenges in testing novel medical technologies in human beings ("translational clinical research"). Current projects are investigating risk, prediction, validity and knowledge value across the trajectory of drug development. Kimmelman directs the .

Other research areas are drug development, animal research, reproducibility, meta-research, and clinical trials.

Selected publications: 


Back to top